{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:05:25Z","timestamp":1789517125335,"version":"build-2803163510"},"reference-count":72,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Macroprolactinemia is a well-recognized cause of hyperprolactinemia and an important diagnostic pitfall in endocrine practice. However, interpretation of published quantitative prolactin data remains sparse as studies vary in confirmation method, assay platform, polyethylene glycol (PEG) recovery cutoff, and reporting of prolactin measurement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence Acquisition<\/jats:title>\n                    <jats:p>PubMed, Embase, Scopus, Web of Science, the Cochrane Library, and Google Scholar were systematically searched. Eligible studies reported macroprolactinemia-specific quantitative prolactin data in patients with confirmed macroprolactinemia defined by PEG precipitation, gel filtration chromatography (GFC), or both. Two reviewers independently performed study selection, data extraction, and quality assessment. Findings were summarized using study-level descriptive synthesis. The review was prospectively registered in PROSPERO and conducted in accordance with PRISMA 2020 guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence Synthesis<\/jats:title>\n                    <jats:p>Forty-five studies encompassing 2853 macroprolactinemia cases from 21 413 screened patients with hyperprolactinemia across 22 countries were included. Among 33 studies eligible for primary quantitative analysis, the median study-level central total prolactin attributed to macroprolactinemia was 61.4 ng\/mL ([IQR] 42.0-80.0; range 28.1-137.6), and the median study-level post-PEG monomeric prolactin was 11.7 ng\/mL (IQR 8.3-13.2; range 4.0-17.0)). The median study-level maximum total prolactin was 264.5 ng\/mL (IQR 97.0-425.5; range 81.8-663.0); extreme elevations were attributable to coexisting prolactinomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In confirmed macroprolactinemia, total prolactin elevation is typically moderate, and post-PEG monomeric prolactin is usually within or near the normal range. The post-PEG monomeric prolactin value, rather than percent recovery alone, is the most informative parameter for distinguishing isolated macroprolactinemia from coexisting true hyperprolactinemia. These quantitative benchmarks may help clinicians to avoid unnecessary investigation or treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag244","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T11:51:29Z","timestamp":1781869889000},"page":"2705-2719","source":"Crossref","is-referenced-by-count":1,"title":["Macroprolactinemia as a diagnostic pitfall in hyperprolactinemia: a systematic review and quantitative synthesis"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6902-1262","authenticated-orcid":false,"given":"Prashant","family":"Yadav","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, and Pituitary Center, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-9385","authenticated-orcid":false,"given":"Amir H","family":"Hamrahian","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, and Pituitary Center, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-2244","authenticated-orcid":false,"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, and Pituitary Center, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2026091519590389100_dgag244-B1","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2023-0502","article-title":"Diagnosis of hyperprolactinemia in women: a position statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)","volume":"68","author":"Glezer","year":"2024","journal-title":"Arch Endocrinol Metab"},{"issue":"21","key":"2026091519590389100_dgag244-B2","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.3390\/ijerph17218199","article-title":"Global prevalence of macroprolactinemia among patients with hyperprolactinemia: a systematic review and meta-analysis","volume":"17","author":"Che Soh","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"2026091519590389100_dgag244-B3","first-page":"245","article-title":"Macroprolactinemia: a mini-review and update on clinical practice","volume":"4","author":"Koniares","year":"2023","journal-title":"F S Rep"},{"issue":"1","key":"2026091519590389100_dgag244-B4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000499694","article-title":"Pitfalls in the diagnostic evaluation of hyperprolactinemia","volume":"109","author":"Vilar","year":"2019","journal-title":"Neuroendocrinology"},{"key":"2026091519590389100_dgag244-B5","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/167132","article-title":"Macroprolactinemia: diagnostic, clinical, and pathogenic significance","volume":"2012","author":"Shimatsu","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"2026091519590389100_dgag244-B6","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/jc.2005-1831","article-title":"Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay","volume":"91","author":"Glezer","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026091519590389100_dgag244-B7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2007.03001.x","article-title":"Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia","volume":"68","author":"Hattori","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2026091519590389100_dgag244-B8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4158\/EP15938.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology disease state clinical review: clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia","volume":"21","author":"Samson","year":"2015","journal-title":"Endocr Pract"},{"issue":"1","key":"2026091519590389100_dgag244-B9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/0004-2730000003002","article-title":"Challenges and pitfalls in the diagnosis of hyperprolactinemia","volume":"58","author":"Vilar","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"2026091519590389100_dgag244-B10","first-page":"63","article-title":"Macroprolactin: from laboratory to clinical practice","volume":"69","author":"Biagetti","year":"2022","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"1","key":"2026091519590389100_dgag244-B11","first-page":"3","article-title":"Prolactin biology and laboratory measurement: an update on physiology and current analytical issues","volume":"39","author":"Saleem","year":"2018","journal-title":"Clin Biochem Rev"},{"issue":"5","key":"2026091519590389100_dgag244-B12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2013.07.002","article-title":"Determination of prolactin: the macroprolactin problem","volume":"27","author":"Fahie-Wilson","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"Pt 3","key":"2026091519590389100_dgag244-B13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/000456329703400305","article-title":"Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol","volume":"34","author":"Fahie-Wilson","year":"1997","journal-title":"Ann Clin Biochem"},{"issue":"10","key":"2026091519590389100_dgag244-B14","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1373\/clinchem.2008.105312","article-title":"Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms","volume":"54","author":"Beltran","year":"2008","journal-title":"Clin Chem"},{"issue":"2","key":"2026091519590389100_dgag244-B15","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2019.020706","article-title":"Optimizing laboratory defined macroprolactin algorithm","volume":"29","author":"\u0160ostari\u0107","year":"2019","journal-title":"Biochem Med (Zagreb)"},{"issue":"4","key":"2026091519590389100_dgag244-B16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2265.2009.03577.x","article-title":"Should macroprolactin be measured in all hyperprolactinaemic sera?","volume":"71","author":"McKenna","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Pt 3","key":"2026091519590389100_dgag244-B17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1258\/acb.2008.007233","article-title":"False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins","volume":"45","author":"Ram","year":"2008","journal-title":"Ann Clin Biochem"},{"issue":"12","key":"2026091519590389100_dgag244-B18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"2026091519590389100_dgag244-B19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026091519590389100_dgag244-B20","doi-asserted-by":"crossref","unstructured":"Yadav P, Hamrahian AH, Salvatori R. 2026. Supplementary tables for \u201cMacroprolactinemia as a diagnostic pitfall in hyperprolactinemia: a systematic review and quantitative synthesis\u201d [data set]. Zenodo. doi:10.5281\/zenodo.20628985.","DOI":"10.1210\/clinem\/dgag244"},{"issue":"2","key":"2026091519590389100_dgag244-B21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ando.2024.101677","article-title":"Evaluation of the analytic performance and macroprolactin sensitivity of a new prolactin immunoassay","volume":"86","author":"David","year":"2025","journal-title":"Ann Endocrinol (Paris)"},{"issue":"9","key":"2026091519590389100_dgag244-B22","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1515\/cclm-2025-0264","article-title":"IgA-type macroprolactin among 130 patients with macroprolactinemia","volume":"63","author":"Ishihara","year":"2025","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"2026091519590389100_dgag244-B23","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1515\/cclm-2025-0177","article-title":"Prevalence and re-evaluation of macroprolactinemia in patients with hyperprolactinemia: a retrospective study in the Turkish population","volume":"63","author":"O\u011fuz","year":"2025","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"2026091519590389100_dgag244-B24","doi-asserted-by":"crossref","first-page":"520\u2013","DOI":"10.14744\/nci.2023.94758","article-title":"The frequency of macroprolactinemia among patients with hyperprolactinemia in a central laboratory of a training and research hospital","volume":"11","author":"Bayraktar","year":"2024","journal-title":"North Clin Istanb"},{"issue":"5","key":"2026091519590389100_dgag244-B25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/cen.15051","article-title":"Macroprolactin over time: is there any point in rechecking it in people with a persistently elevated serum prolactin?","volume":"100","author":"Livingston","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026091519590389100_dgag244-B26","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2023-0391","article-title":"Usefulness of prolactin levels in predicting the etiology of hyperprolactinemia in a cohort of 770 patients","volume":"68","author":"Vilar","year":"2024","journal-title":"Arch Endocrinol Metab"},{"issue":"3","key":"2026091519590389100_dgag244-B27","first-page":"100","article-title":"Relevance and therapeutic implication of macroprolactinemia detection using PEG 6000 in women of childbearing age with hyperprolactinemia: experience at a tertiary hospital","volume":"28","author":"Boli","year":"2023","journal-title":"J Endocrinol Metab Diabetes S Afr"},{"key":"2026091519590389100_dgag244-B28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117358","article-title":"Comparison of PEG precipitation and ultrafiltration treatment for serum macroprolactin in Chinese patients with hyperprolactinemia","volume":"544","author":"Ke","year":"2023","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2026091519590389100_dgag244-B29","first-page":"BC12","article-title":"Prevalence of macroprolactinaemia in women with hyperprolactinaemia: a retrospective study","volume":"16","author":"Almeida","year":"2022","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"2026091519590389100_dgag244-B30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000519094","article-title":"Prevalence of macroprolactinemia in patients with hyperprolactinemia using Roche Elecsys platform in a large tertiary referral center in UAE","volume":"27","author":"Al Nuaimi","year":"2021","journal-title":"Dubai Diabetes Endocrinol J"},{"issue":"2","key":"2026091519590389100_dgag244-B31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/jhrs.jhrs_168_20","article-title":"Persistent idiopathic prolactin elevation merits macroprolactin estimation: a case report and review of literature","volume":"14","author":"Gautam","year":"2021","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"2026091519590389100_dgag244-B32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12902-021-00861-z","article-title":"Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin","volume":"21","author":"Hu","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"2026091519590389100_dgag244-B33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.11604\/pamj.2020.36.8.22923","article-title":"Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center","volume":"36","author":"Chutpiboonwat","year":"2020","journal-title":"Pan Afr Med J"},{"issue":"3","key":"2026091519590389100_dgag244-B34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jalm\/jfaa015","article-title":"Macroprolactinemia detection by magnetically assisted polyethylene glycol precipitation: potential for automation","volume":"5","author":"Smith","year":"2020","journal-title":"J Appl Lab Med"},{"issue":"2","key":"2026091519590389100_dgag244-B35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12020-018-1770-6","article-title":"Prevalence and reproductive manifestations of macroprolactinemia","volume":"63","author":"Kalsi","year":"2019","journal-title":"Endocrine"},{"issue":"3","key":"2026091519590389100_dgag244-B36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/labmed-2019-0046","article-title":"Macroprolactin: an overlooked reason of hyperprolactinemia","volume":"43","author":"Muhtaroglu","year":"2019","journal-title":"J Lab Med"},{"issue":"11","key":"2026091519590389100_dgag244-B37","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1515\/cclm-2016-0902","article-title":"Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia","volume":"55","author":"Overgaard","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"2026091519590389100_dgag244-B38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-14-1073","article-title":"Macroprolactinaemia: a biological diagnostic strategy from the study of 222 patients","volume":"172","author":"Parlant-Pinet","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026091519590389100_dgag244-B39","first-page":"359","article-title":"Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation","volume":"65","author":"Beda-Maluga","year":"2014","journal-title":"J Physiol Pharmacol"},{"issue":"4","key":"2026091519590389100_dgag244-B40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/cen.12266","article-title":"Evaluation of macroprolactinemia in 259 women under investigation for polycystic ovary syndrome","volume":"80","author":"Hayashida","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026091519590389100_dgag244-B41","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/478282","article-title":"Frequency of macroprolactinemia in hyperprolactinemic women presenting with menstrual irregularities, galactorrhea, and\/or infertility: etiology and clinical manifestations","volume":"2013","author":"Lea\u00f1os-Miranda","year":"2013","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2026091519590389100_dgag244-B42","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s12020-013-9925-y","article-title":"Macroprolactinemia in hyperprolactinemic infertile women","volume":"44","author":"Thirunavakkarasu","year":"2013","journal-title":"Endocrine"},{"issue":"2","key":"2026091519590389100_dgag244-B43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12020-011-9576-9","article-title":"Clinical and radiological findings in macroprolactinemia","volume":"41","author":"Isik","year":"2012","journal-title":"Endocrine"},{"issue":"1","key":"2026091519590389100_dgag244-B44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5812\/ijem.3600","article-title":"140 cases of macroprolactinemia: selected clinical and technical laboratory aspects","volume":"10","author":"Jeske","year":"2012","journal-title":"Int J Endocrinol Metab"},{"issue":"2","key":"2026091519590389100_dgag244-B45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.kjms.2011.10.030","article-title":"The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients","volume":"28","author":"Lu","year":"2012","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"2026091519590389100_dgag244-B46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12020-011-9536-4","article-title":"Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed","volume":"41","author":"Tamer","year":"2012","journal-title":"Endocrine"},{"issue":"5","key":"2026091519590389100_dgag244-B47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.kjms.2010.07.002","article-title":"Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia","volume":"27","author":"Can","year":"2011","journal-title":"Kaohsiung J Med Sci"},{"issue":"3-4","key":"2026091519590389100_dgag244-B48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2009.10.020","article-title":"Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin","volume":"411","author":"McCudden","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2026091519590389100_dgag244-B49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF03346388","article-title":"Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients","volume":"31","author":"Vilar","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026091519590389100_dgag244-B50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1590\/S0004-27302007000100014","article-title":"Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia","volume":"51","author":"Vilar","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"2026091519590389100_dgag244-B51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4158\/EP.12.3.275","article-title":"Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia","volume":"12","author":"Alfonso","year":"2006","journal-title":"Endocr Pract"},{"issue":"2","key":"2026091519590389100_dgag244-B52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1677\/joe.1.06871","article-title":"Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia","volume":"190","author":"Hattori","year":"2006","journal-title":"J Endocrinol"},{"issue":"7","key":"2026091519590389100_dgag244-B53","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1373\/clinchem.2005.065854","article-title":"Specificity and clinical utility of methods for the detection of macroprolactin","volume":"52","author":"Kavanagh","year":"2006","journal-title":"Clin Chem"},{"issue":"2","key":"2026091519590389100_dgag244-B54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.24953\/turkjped.2006.2616","article-title":"Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia","volume":"48","author":"Tutunculer","year":"2006","journal-title":"Turk J Pediatr"},{"issue":"6","key":"2026091519590389100_dgag244-B55","first-page":"402","article-title":"Evaluation of polyethylene glycol precipitation as screening test for macroprolactinemia using Architect immunoanalyser","volume":"20","author":"Germano","year":"2005","journal-title":"Immunoanal. Biol. Sp\u00e9c"},{"issue":"7","key":"2026091519590389100_dgag244-B56","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2004-2234","article-title":"The impact on clinical practice of routine screening for macroprolactin","volume":"90","author":"Gibney","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026091519590389100_dgag244-B57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF03345144","article-title":"Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods","volume":"26","author":"Amadori","year":"2003","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2026091519590389100_dgag244-B58","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/humrep\/deg172","article-title":"Macroprolactinaemia associated with prolactin adenoma","volume":"18","author":"Mounier","year":"2003","journal-title":"Hum Reprod"},{"issue":"3","key":"2026091519590389100_dgag244-B59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2265.2003.01852.x","article-title":"Clinical and radiological features of patients with macroprolactinaemia","volume":"59","author":"Strachan","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2026091519590389100_dgag244-B60","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1373\/49.9.1504","article-title":"Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia","volume":"49","author":"Suliman","year":"2003","journal-title":"Clin Chem"},{"issue":"3","key":"2026091519590389100_dgag244-B61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2265.2002.01586.x","article-title":"Screening for macroprolactinaemia and pituitary imaging studies","volume":"57","author":"Hauache","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1-2","key":"2026091519590389100_dgag244-B62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0009-8981(01)00733-1","article-title":"Free prolactin determinations in hyperprolactinemic men with suspicion of macroprolactinemia","volume":"316","author":"Sapin","year":"2002","journal-title":"Clin Chim Acta"},{"issue":"12","key":"2026091519590389100_dgag244-B63","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1210\/jc.2001-011943","article-title":"Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026091519590389100_dgag244-B64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jcem.87.2.8272","article-title":"Macroprolactinemia revisited: a study on 106 patients","volume":"87","author":"Vallette-Kasic","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026091519590389100_dgag244-B65","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jcem.86.6.7521","article-title":"Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method","volume":"86","author":"Leslie","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026091519590389100_dgag244-B66","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1515\/cclm-2022-0459","article-title":"Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia","volume":"60","author":"Smith","year":"2022","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"2026091519590389100_dgag244-B67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1258\/acb.2008.007262","article-title":"Polyethylene glycol precipitation: proceed with care","volume":"45","author":"Fahie-Wilson","year":"2008","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"2026091519590389100_dgag244-B68","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1515\/cclm-2020-0858","article-title":"Assessment of intraindividual agreement in prolactin results after post-polyethylene glycol precipitation test for the estimation of macroprolactin. Should the precipitation procedure be repeated in the same patient?","volume":"59","author":"Jimenez-Anon","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"2026091519590389100_dgag244-B69","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091519590389100_dgag244-B70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2020.12.018","article-title":"Circulating macroprolactin exhibits molecular heterogeneity and is not exclusively an antibody complex","volume":"514","author":"Nguyen","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2026091519590389100_dgag244-B71","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"2026091519590389100_dgag244-B72","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2025-0152","article-title":"Position statement on macroprolactinemia from the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology\/Laboratory Medicine (SBPC\/ML)","volume":"69","author":"Glezer","year":"2025","journal-title":"Arch Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag244\/68568995\/dgag244.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/10\/2705\/68568995\/dgag244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/10\/2705\/68568995\/dgag244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:59:17Z","timestamp":1789516757000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/10\/2705\/8712925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":72,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,6,22]]},"published-print":{"date-parts":[[2026,9,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag244","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,6,22]]}}}